Literature DB >> 19497253

Origins of the new influenza A(H1N1) virus: time to take action.

G M Nava1, M S Attene-Ramos, J K Ang, M Escorcia.   

Abstract

To gain insight into the possible origins of the 2009 outbreak of new influenza A(H1N1), we performed two independent analyses of genetic evolution of the new influenza A(H1N1) virus. Firstly, protein homology analyses of more than 400 sequences revealed that this virus most likely evolved from recent swine viruses. Secondly, phylogenetic analyses of 5,214 protein sequences of influenza A(H1N1) viruses (avian, swine and human) circulating in North America for the last two decades (from 1989 to 2009) indicated that the new influenza A(H1N1) virus possesses a distinctive evolutionary trait (genetic distinctness). This appears to be a particular characteristic in pig-human interspecies transmission of influenza A. Thus these analyses contribute to the evidence of the role of pig populations as "mixing vessels" for influenza A(H1N1) viruses.

Entities:  

Mesh:

Year:  2009        PMID: 19497253     DOI: 10.2807/ese.14.22.19228-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  14 in total

1.  Wild bird's-eye view of influenza virus A(H1N1) phylogenetic evolution.

Authors:  Antoinette J Piaggio; Larry Clark; Alan B Franklin; Sergios-Orestis Kolokotronis
Journal:  Ecohealth       Date:  2010-05-11       Impact factor: 3.184

Review 2.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

3.  Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.

Authors:  Jae-Min Song; Jaber Hossain; Dae-Goon Yoo; Aleksandr S Lipatov; C Todd Davis; Fu-Shi Quan; Li-Mei Chen; Robert J Hogan; Ruben O Donis; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2010-06-26       Impact factor: 3.616

4.  Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Aswani Vunnava; Dae-Goon Yoo; Jae-Min Song; Mark R Prausnitz; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  Utilizing spatiotemporal analysis of influenza-like illness and rapid tests to focus swine-origin influenza virus intervention.

Authors:  J Gaines Wilson; Jessica Ballou; Chris Yan; Susan P Fisher-Hoch; Belinda Reininger; Jennifer Gay; Jennifer Salinas; Pablo Sanchez; Yvette Salinas; Fidel Calvillo; Leonel Lopez; Ionara P Delima; Joseph B McCormick
Journal:  Health Place       Date:  2010-08-14       Impact factor: 4.078

6.  Swine- Origin Influenza A (H1N1) Pandemic Revisited.

Authors:  Bc Mathew; Rs Daniel; Iw Campbell
Journal:  Libyan J Med       Date:  2009-09-01       Impact factor: 1.657

7.  Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.

Authors:  Min-Chul Kim; Jong-Seok Lee; Young-Man Kwon; Eunju O; Youn-Jeong Lee; Jun-Gu Choi; Bao-Zhong Wang; Richard W Compans; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2013-06-27       Impact factor: 5.970

8.  Phylogenetic analysis of H1N1 sequences from pandemic infections during 2009 in India.

Authors:  Guntupally Balaswamy Arti Flavia; Kalimuthusamy Natarajaseenivasan
Journal:  Bioinformation       Date:  2011-02-15

9.  Finding a new drug and vaccine for emerging swine flu: what is the concept?

Authors:  Viroj Wiwanitkit
Journal:  Biologics       Date:  2009-09-15

10.  From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge?

Authors:  Adrian J Gibbs; John S Armstrong; Jean C Downie
Journal:  Virol J       Date:  2009-11-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.